Assessment of Fatty Acid/Carnitine Homeostasis in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)

Not Applicable

Completed

• Conditions: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis; Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)

• Registration Number: ACTRN12612001209886
• Lead Sponsor: niversity of South Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1.Participant is >=18 years of age at the time of informed consent.
2.Participant is a male or non-pregnant, non-lactating female.
3.Participant is either:
i.a patient diagnosed with CFS/ME by a physician according to the standard diagnostic criteria; or
ii.a healthy subject with no clinically significant conditions.
4.Participant is aware of the study procedures and the risks involved and voluntarily agrees to participate by providing written informed consent.

Exclusion Criteria

1.Participant has received treatment with L-carnitine or any carnitine derivatives within 2 months of study participation.
2.Participant has received treatment with fatty acid-containing products within 2 months of study participation.
3.Participant has received treatment with a pharmacologic agent known to alter fatty acid/carnitine homeostasis within 2 months of study participation.
4.Participant has a known blood-borne viral infection, including HIV, Hepatitis B or Hepatitis C.
5.Participant has a history or current evidence of any condition, therapy or laboratory abnormality that, in the opinion of the investigator, might affect the results of the study or may not be in the best interest of the individual to participate.
6.Participant has participated in a clinical trial within 2 months of study participation that, in the opinion of the investigator, might affect the results of the study or may not be in the best interest of the individual to participate.

Study & Design

• Study Type: Observational
• Study Design: Not specified